Returning negative results from large-scale genomic screening: Experiences from the eMERGE III network.

genomic screening negative results return of results

Journal

American journal of medical genetics. Part A
ISSN: 1552-4833
Titre abrégé: Am J Med Genet A
Pays: United States
ID NLM: 101235741

Informations de publication

Date de publication:
02 2021
Historique:
entrez: 1 9 2022
pubmed: 1 2 2021
medline: 1 2 2021
Statut: ppublish

Résumé

Population-based genomic screening has the potential to improve health outcomes by identifying genetic causes of disease before they occur. While much attention has been paid to supporting the needs of the small percentage of patients who will receive a life-altering positive genomic screening result that requires medical attention, little attention has been given to the communication of negative screening results. As there are currently no best practices for returning negative genomic screening results, we drew on experiences across the electronic medical records and genomics (eMERGE) III Network to highlight the diversity of reporting methods employed, challenges encountered in reporting negative test results, and "lessons learned" across institutions. A 60-item survey that consisted of both multiple choice and open-ended questions was created to gather data across institutions. Even though institutions independently developed procedures for reporting negative results, and had very different study populations, we identified several similarities of approach, including but not limited to: returning results by mail, placing results in the electronic health record via an automated process, reporting results to participants' primary care provider, and providing genetic counseling to interested patients at no cost. Differences in procedures for reporting negative results included: differences in terminology used to describe negative results, definitions of negative results, guidance regarding the meaning of negative results for participants and their family members, and recommendations for clinical follow up. Our findings highlight emerging practices for reporting negative genomic screening results and highlight the need to create patient education and clinical support tools for reporting negative screening results.

Identifiants

pubmed: 36046768
doi: 10.1002/ajmg.a.62002
pmc: PMC9426643
mid: NIHMS1791522
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

508-516

Subventions

Organisme : NHGRI NIH HHS
ID : U01 HG011172
Pays : United States
Organisme : NHGRI NIH HHS
ID : U01 HG008657
Pays : United States
Organisme : NHGRI NIH HHS
ID : U01 HG008672
Pays : United States
Organisme : NHGRI NIH HHS
ID : U01 HG008684
Pays : United States
Organisme : NHGRI NIH HHS
ID : U01 HG008679
Pays : United States
Organisme : NHGRI NIH HHS
ID : U01 HG008666
Pays : United States
Organisme : NHGRI NIH HHS
ID : U01 HG008680
Pays : United States
Organisme : NHGRI NIH HHS
ID : U01 HG008673
Pays : United States
Organisme : NHGRI NIH HHS
ID : U01 HG008685
Pays : United States
Organisme : NHGRI NIH HHS
ID : U01 HG006379
Pays : United States
Organisme : NHGRI NIH HHS
ID : U01 HG008701
Pays : United States

Déclaration de conflit d'intérêts

CONFLICT OF INTEREST The authors declare no conflicts of interest.

Références

J Pers Med. 2020 May 13;10(2):
pubmed: 32413979
J Pers Med. 2020 Apr 17;10(2):
pubmed: 32316380
Genet Med. 2020 Dec;22(12):1994-2002
pubmed: 32669678
Genet Med. 2011 Jun;13(6):499-504
pubmed: 21558861
J Med Genet. 2019 May;56(5):317-324
pubmed: 30580287
Eur J Clin Invest. 2010 Jan;40(1):64-8
pubmed: 20055897
Genet Med. 2019 Feb;21(2):409-416
pubmed: 29875426
Health Commun. 2017 Sep;32(9):1104-1111
pubmed: 27573590
Sociol Health Illn. 2016 Nov;38(8):1303-1317
pubmed: 27538589
Genet Med. 2018 Oct;20(10):1157-1158
pubmed: 29388941
Am J Hum Genet. 2018 Sep 6;103(3):358-366
pubmed: 30122538
Health Aff (Millwood). 2018 May;37(5):694-701
pubmed: 29733705
Am J Hum Genet. 2019 Sep 5;105(3):588-605
pubmed: 31447099
J Pers Med. 2018 Jan 03;8(1):
pubmed: 29301385

Auteurs

Kelsey Stuttgen Finn (KS)

Biomedical Ethics Research Program, Mayo Clinic, Rochester, Minnesota.
Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.

John Lynch (J)

Department of Communication, University of Cincinnati, Cincinnati, Ohio.

Sharon Aufox (S)

Center for Genomic Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.

Harris T. Bland (HT)

Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tennessee.

Wendy Chung (W)

Department of Pediatrics, Columbia University, New York, New York.

Colin Halverson (C)

School of Medicine, Indiana University-Purdue University, Indianapolis, Indiana.

Scott Hebbring (S)

Center for Human Genetics, Marshfield Clinic Research Institute, Marshfield, Wisconsin.

Christin Hoell (C)

Center for Genomic Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.

Ingrid Holm (I)

Department of Pediatrics, Harvard Medical School, Boston, Massachusetts.
Division of Genetics and Genomics, Boston Children's Hospital, Boston, Massachusetts.

Gail Jarvik (G)

Division of Medical Genetics, School of Medicine, University of Washington, Seattle, Washington.

Iftikhar Kullo (I)

Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.

Kathleen Leppig (K)

Genetic Services, Kaiser Permanente of Washington, Seattle, Washington.
Biomedical and Health Informatics, University of Washington, Seattle, Washington.

Melanie Myers (M)

College of Medicine, University of Cincinnati, Cincinnati, Ohio.
Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio.

Cynthia Prows (C)

Department of Pediatrics, Cincinnati Children's Hospital Medical Center, University of Cincinnati, Cincinnati, Ohio.

Hila Milo Rasouly (HM)

Department of Medicine, Division of Nephrology, Columbia University Irving Medical Center, New York, New York.

Rajbir Singh (R)

Department of Microbiology and Immunology, Meharry Medical College, Nashville, Tennessee.
Department of Obstetrics and Gynecology, Meharry Medical College, Nashville, Tennessee.

Georgia Weisner (G)

Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
Vanderbilt Clinical and Translational Hereditary Cancer Program, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, Tennessee.

Janet Williams (J)

Geisinger Genomic Medicine Institute, Danville, Pennsylvania.

Julia Wynn (J)

Department of Pediatrics, Columbia University, New York, New York.

Maureen Smith (M)

Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, Illinois.

Richard Sharp (R)

Biomedical Ethics Research Program, Mayo Clinic, Rochester, Minnesota.
Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.

Classifications MeSH